Chardan Capital Reiterates Orchestra BioMed Holdings (OBIO) Buy Recommendation

Fintel reports that on August 11, 2023, Chardan Capital reiterated coverage of Orchestra BioMed Holdings (NASDAQ:OBIO) with a Buy recommendation.

admin